Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 06:03 am Sale | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Point72 Asset Management, L.P. | 825,000 3.800% | -425,000 (-34.00%) | Filing History |
| 2024-02-14 06:01 am Sale | 2023-12-31 | 13G | CUTERA INC CUTRQ | Point72 Asset Management, L.P. | 214,800 1.100% | -929,607 (-81.23%) | Filing History |
| 2024-02-12 4:24 pm Purchase | 2024-02-02 | 13G | Annexon, Inc. ANNX | Point72 Asset Management, L.P. | 4,868,603 6.200% | 4,868,603 (New Position) | Filing History |
| 2024-02-09 4:08 pm Purchase | 2024-02-06 | 13G | Vaccinex, Inc. VCNX | Point72 Asset Management, L.P. | 413,818 9.900% | 413,818 (New Position) | Filing History |
| 2024-02-08 4:53 pm Purchase | 2024-02-07 | 13G | JOYY Inc. JOYY | Point72 Asset Management, L.P. | 45,329,900 5.100% | 45,329,900 (New Position) | Filing History |
| 2024-02-07 4:25 pm Purchase | 2024-02-06 | 13G | Alto Neuroscience, Inc. ANRO | Point72 Asset Management, L.P. | 1,692,778 6.300% | 1,692,778 (New Position) | Filing History |
| 2024-02-05 4:34 pm Purchase | 2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT | Point72 Asset Management, L.P. | 1,612,639 5.300% | 1,612,639 (New Position) | Filing History |
| 2024-01-31 4:55 pm Purchase | 2024-01-30 | 13G | Iterum Therapeutics plc ITRM | Point72 Asset Management, L.P. | 850,001 6.300% | 850,001 (New Position) | Filing History |
| 2024-01-31 4:54 pm Purchase | 2024-01-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 4,867,706 5.200% | 3,680,108 (+309.88%) | Filing History |
| 2024-01-29 4:40 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Point72 Asset Management, L.P. | 388,676 8.800% | 388,676 (New Position) | Filing History |
| 2024-01-25 4:19 pm Purchase | 2024-01-24 | 13G | Fate Therapeutics, Inc. FATE | Point72 Asset Management, L.P. | 4,945,146 5.000% | 4,945,146 (New Position) | Filing History |
| 2024-01-04 4:15 pm Purchase | 2024-01-03 | 13G | C4 Therapeutics, Inc. CCCC | Point72 Asset Management, L.P. | 2,676,696 5.400% | 2,676,696 (New Position) | Filing History |
| 2024-01-02 4:15 pm Purchase | 2023-12-21 | 13G | Syros Pharmaceuticals, Inc. SYRS | Point72 Asset Management, L.P. | 1,471,771 5.700% | 1,471,771 (New Position) | Filing History |
| 2023-12-28 4:15 pm Purchase | 2023-12-27 | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management, L.P. | 10,702,598 5.100% | 8,012,692 (+297.88%) | Filing History |
| 2023-12-18 4:15 pm Purchase | 2023-12-07 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 3,186,077 5.500% | 2,818,071 (+765.77%) | Filing History |
| 2023-12-11 4:15 pm Purchase | 2023-11-29 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Point72 Asset Management, L.P. | 3,470,691 5.100% | 3,470,691 (New Position) | Filing History |
| 2023-12-01 4:15 pm Purchase | 2023-11-30 | 13G | FARFETCH LTD FTCHQ | Point72 Asset Management, L.P. | 18,765,409 5.300% | 18,765,409 (New Position) | Filing History |
| 2023-11-20 4:15 pm Purchase | 2023-11-10 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 3,622,136 6.600% | 3,622,136 (New Position) | Filing History |
| 2023-11-16 5:00 pm Purchase | 2023-11-15 | 13G | Lyra Therapeutics, Inc. LYRA | Point72 Asset Management, L.P. | 60,000 5.400% | 60,000 (New Position) | Filing History |
| 2023-11-09 4:27 pm Purchase | 2023-11-03 | 13G | Korro Bio, Inc. KRRO | Point72 Asset Management, L.P. | 542,657 6.800% | 542,657 (New Position) | Filing History |